These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 26518371)

  • 21. The roles of purinergic signaling in psychiatric disorders.
    Cieślak M; Czarnecka J; Roszek K
    Acta Biochim Pol; 2016; 63(1):1-9. PubMed ID: 26495439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission.
    Liñán-Rico A; Wunderlich JE; Enneking JT; Tso DR; Grants I; Williams KC; Otey A; Michel K; Schemann M; Needleman B; Harzman A; Christofi FL
    Neuropharmacology; 2015 Aug; 95():83-99. PubMed ID: 25724083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal exposure to valproic acid induces alterations in the expression and activity of purinergic receptors in the embryonic rat brain.
    Babiec L; Wilkaniec A; Adamczyk A
    Folia Neuropathol; 2022; 60(4):390-402. PubMed ID: 36734381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introductory overview of purinergic signalling.
    Burnstock G
    Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
    Fumagalli M; Lecca D; Abbracchio MP
    Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purinergic signaling in diabetes and metabolism.
    Jain S; Jacobson KA
    Biochem Pharmacol; 2021 May; 187():114393. PubMed ID: 33359363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of purines in brain development, from neuronal proliferation to synaptic refinement.
    Rimbert S; Moreira JB; Xapelli S; Lévi S
    Neuropharmacology; 2023 Oct; 237():109640. PubMed ID: 37348675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purinergic signaling in the retina: From development to disease.
    Ventura ALM; Dos Santos-Rodrigues A; Mitchell CH; Faillace MP
    Brain Res Bull; 2019 Sep; 151():92-108. PubMed ID: 30458250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Purinergic Signaling in Acupuncture Therapeutics.
    Lv ZY; Yang YQ; Yin LM
    Am J Chin Med; 2021; 49(3):645-659. PubMed ID: 33641652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nucleotide receptors--structure and function, history and perspectives].
    Barańska J
    Postepy Biochem; 2014; 60(4):424-37. PubMed ID: 25807822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of astrocytes in purine-mediated reparative processes in the brain.
    Ciccarelli R; Ballerini P; Sabatino G; Rathbone MP; D'Onofrio M; Caciagli F; Di Iorio P
    Int J Dev Neurosci; 2001 Jul; 19(4):395-414. PubMed ID: 11378300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders.
    Huang L; Otrokocsi L; Sperlágh B
    Brain Res Bull; 2019 Sep; 151():55-64. PubMed ID: 30721770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic transmission in depressive disorders.
    Szopa A; Socała K; Serefko A; Doboszewska U; Wróbel A; Poleszak E; Wlaź P
    Pharmacol Ther; 2021 Aug; 224():107821. PubMed ID: 33607148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression.
    Sikka P; Behl T; Chandel P; Sehgal A; Singh S; Makeen HA; Albratty M; Alhazmi HA; Meraya AM
    Neurotox Res; 2022 Oct; 40(5):1570-1585. PubMed ID: 35930172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular ATP signaling and clinical relevance.
    Dou L; Chen YF; Cowan PJ; Chen XP
    Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic neurone-glia signalling in cognitive-related pathologies.
    Illes P; Verkhratsky A
    Neuropharmacology; 2016 May; 104():62-75. PubMed ID: 26256423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Volpini R; Cristalli G
    Curr Med Chem; 2011; 18(10):1444-63. PubMed ID: 21428896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells.
    Zhao LF; Iwasaki Y; Oki Y; Tsugita M; Taguchi T; Nishiyama M; Takao T; Kambayashi M; Hashimoto K
    J Neuroendocrinol; 2006 Apr; 18(4):273-8. PubMed ID: 16503922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The participation of plasma membrane hemichannels to purinergic signaling.
    Baroja-Mazo A; Barberà-Cremades M; Pelegrín P
    Biochim Biophys Acta; 2013 Jan; 1828(1):79-93. PubMed ID: 22266266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.